Autophagy, endolysosomes and extracellular space in autoimmune and innate immune defects
11 affiliations
- 1Department of Pediatrics, Faculty of Medicine and University Hospital Cologne, University of Cologne
- 2Max-Planck-Institute for Biology of Ageing and Cologne Excellence Cluster for Ageing-Associated Diseases
- 3Department of Immunology, Great Ormond Street Hospital for Children NHS Foundation Trust
- 4UCL Great Ormond Street Institute of Child Health, Departement of Infection, Immunity & Inflammation, University College London
- 5Children’s Neuroscience, Evelina London Children’s Hospital at Guy’s and St Thomas’ NHS Foundation Trust
- 6Faculty of Life Sciences and Medicine, King’s College London
- 7Department of Neurology, Hunan Children’s Hospital
- 8Helios Klinikum Krefeld, HMU Health Medical University Campus Düsseldorf/Krefeld
- 9Randall Centre for Cell and Molecular Biophysics, Muscle Signaling Section, Faculty of Life Sciences and Medicine (FoLSM), King's College London
- 10Center for Rare Diseases, Faculty of Medicine and University Hospital Cologne, University of Cologne
- 11Center for Molecular Medicine Cologne (CMMC), Faculty of Medicine and University Hospital Cologne, University of Cologne
Abstract
Autophagy is increasingly recognized as a central immunological process whose roles extend far beyond intracellular recycling. By coordinating lysosomal degradation, organelle quality control, selective antimicrobial clearance, and inflammatory signal termination, autophagy acts as a decisive checkpoint at the crossroads between protective innate immunity and pathological immune persistence. Xenophagy, the selective autophagic elimination of intracellular pathogens, is a particularly important process at the interface between host defense, endosomal trafficking and immune resolution. Distinct monogenic disorders affecting EPG5 -dependent autophagosome-lysosome fusion, LYST -dependent lysosomal and granule organization, or RAB27A -dependent lytic-granule exocytosis illustrate how different lesions in intracellular trafficking can impair microbial handling and contribute to immune dysregulation. Functioning autophagy also boosts cellular resilience through the removal of intracellular debris via exocytosis. In parallel, neutrophil extracellular traps (NETs) have emerged as potent antimicrobial structures that also aid cellular resilience but have a dual role in immunity: while NET formation can restrict pathogen dissemination, excessive or insufficiently cleared NETs expose chromatin, histones, proteases and modified autoantigens that can drive autoimmunity, thromboinflammation and tissue damage. In this review, we discuss the intricate links between xenophagy, its intracellular endolysosomal hubs, and its extracellular targets and traps as an integrated cell-biological and immunopathological network. We highlight how autophagy initiation and verified degradative flux, mitochondrial quality control, reactive oxygen species, peptidylarginine deiminase 4 (PAD4)-dependent chromatin decondensation, and endolysosomal trafficking may intersect with neutrophil effector functions in a stimulus- and model-dependent manner. Particular emphasis is placed on endosomal checkpoint proteins such as TOM1, which link ubiquitinated cargo sorting, IL-1R1/NF-κB signal termination, autophagosome maturation, and lysosomal degradation. We propose that defective endosomal and autophagic resolution mechanisms blur the boundary between efficient antimicrobial defense and chronic inflammatory auto-amplification. This concept is highly relevant for a wide range of autoimmune conditions, including systemic lupus erythematosus, rheumatoid arthritis, ANCA-associated vasculitis, autoinflammatory syndromes, immunodeficiency, and neuroinflammatory disease. Finally, we discuss therapeutic strategies aimed at restoring immune resolution, including modulation of autophagy, enhancement of NET clearance, targeting of PAD4 and inflammasome pathways as well as correction of endolysosomal trafficking defects. Understanding these intricately linked networks may open new avenues for mechanism-based treatment of autoimmune and innate immune disorders.
Related
- La gran simuladora: tres casos de enfermedad inflamatoria intestinal asociada a errores innatos de la inmunidad The Great Imposter: Three Cases of Inflammatory Bowel Disease Associated with Innate Immune Defects
- Autophagy Defects and Mitochondrial Retention in Erythroid Diseases
- Targeting the secretory autophagy–extracellular vesicle interface: fate decisions and translational opportunities
- Pharmacological Activation of Autophagy Ameliorates Neuromuscular-Associated Defects and Extends Lifespan in a Caenorhabditis elegans Model of Spinal Muscular Atrophy.
- A let-7a-5p-engineered extracellular vesicle-laden bioactive scaffold promotes immunomodulation and regeneration of segmental tracheal defects.
BibTeX
@article{schuler2026autophagy,
title = {{Autophagy, endolysosomes and extracellular space in autoimmune and innate immune defects}},
author = {Juliane Schuler and Lea Tollmann and Robert Walter Körner and Birk Möller and Emil Schober and Charlotte Schöner and Maaike Kusters and Ming Lim and Tim Niehues and Heinz Jungbluth and Hormos S. Dafsari},
journal = {Frontiers in Immunology},
year = {2026},
month = oct,
doi = {10.3389/fimmu.2026.1947320},
url = {https://www.frontiersin.org/articles/10.3389/fimmu.2026.1947320/full},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Autophagy, endolysosomes and extracellular space in autoimmune and innate immune defects
AU - Juliane Schuler
AU - Lea Tollmann
AU - Robert Walter Körner
AU - Birk Möller
AU - Emil Schober
AU - Charlotte Schöner
AU - Maaike Kusters
AU - Ming Lim
AU - Tim Niehues
AU - Heinz Jungbluth
AU - Hormos S. Dafsari
PY - 2026
DA - 2026/10/07
JO - Frontiers in Immunology
DO - 10.3389/fimmu.2026.1947320
UR - https://www.frontiersin.org/articles/10.3389/fimmu.2026.1947320/full
AB - Autophagy is increasingly recognized as a central immunological process whose roles extend far beyond intracellular recycling. By coordinating lysosomal degradation, organelle quality control, selective antimicrobial clearance, and inflammatory signal termination, autophagy acts as a decisive checkpoint at the crossroads between protective innate immunity and pathological immune persistence. Xenophagy, the selective autophagic elimination of intracellular pathogens, is a particularly important process at the interface between host defense, endosomal trafficking and immune resolution. Distinct monogenic disorders affecting EPG5 -dependent autophagosome-lysosome fusion, LYST -dependent lysosomal and granule organization, or RAB27A -dependent lytic-granule exocytosis illustrate how different lesions in intracellular trafficking can impair microbial handling and contribute to immune dysregulation. Functioning autophagy also boosts cellular resilience through the removal of intracellular debris via exocytosis. In parallel, neutrophil extracellular traps (NETs) have emerged as potent antimicrobial structures that also aid cellular resilience but have a dual role in immunity: while NET formation can restrict pathogen dissemination, excessive or insufficiently cleared NETs expose chromatin, histones, proteases and modified autoantigens that can drive autoimmunity, thromboinflammation and tissue damage. In this review, we discuss the intricate links between xenophagy, its intracellular endolysosomal hubs, and its extracellular targets and traps as an integrated cell-biological and immunopathological network. We highlight how autophagy initiation and verified degradative flux, mitochondrial quality control, reactive oxygen species, peptidylarginine deiminase 4 (PAD4)-dependent chromatin decondensation, and endolysosomal trafficking may intersect with neutrophil effector functions in a stimulus- and model-dependent manner. Particular emphasis is placed on endosomal checkpoint proteins such as TOM1, which link ubiquitinated cargo sorting, IL-1R1/NF-κB signal termination, autophagosome maturation, and lysosomal degradation. We propose that defective endosomal and autophagic resolution mechanisms blur the boundary between efficient antimicrobial defense and chronic inflammatory auto-amplification. This concept is highly relevant for a wide range of autoimmune conditions, including systemic lupus erythematosus, rheumatoid arthritis, ANCA-associated vasculitis, autoinflammatory syndromes, immunodeficiency, and neuroinflammatory disease. Finally, we discuss therapeutic strategies aimed at restoring immune resolution, including modulation of autophagy, enhancement of NET clearance, targeting of PAD4 and inflammasome pathways as well as correction of endolysosomal trafficking defects. Understanding these intricately linked networks may open new avenues for mechanism-based treatment of autoimmune and innate immune disorders.
SN - 1664-3224
ER -